Find the latest oncology news for your sub-specialty area
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the…
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to…
In patients with chronic lymphocytic leukaemia (CLL), the rate of disease growth is apt to…
Nearly 90 per cent of children with acute lymphoblastic leukaemia (ALL) survive, yet the same…
A study has shown that more than half of physicians – primary care doctors and…
A decade-old treatment recommendation for people with cancer to take a “slowly slowly” approach to…
Screening millions of healthy people for their risk of disease can be cost-effective. But it…
A study published today in PLOS ONE discovered the origin of severely disfiguring masses of cells,…
New findings from researchers in the Perelman School of Medicine at the University of Pennsylvania…